Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 472.57% and ...

Leerink Partners maintained a positive outlook on shares of Eli Lilly and Company (NYSE:LLY) shares, reiterating an Outperform rating and a price target of $950.00. The pharmaceutical giant, currently ...

Guggenheim analysts revised their price target for Eli Lilly (NYSE:LLY) shares, reducing it to $973.00 from the previous $995 ...

N-Power Medicine, backed by Merck GHI, announced the acquisition of Syapse Holdings. Samsung Biologics and LigaChem extended their ADC services deal. Publicis Worldwide merged with Leo Burnett to form ...

Potential antitrust deregulation could foster a more favourable environment for larger M&A deals, though skepticism remains.

Eli Lilly has announced a central nervous system research tie-up with UK biotech Evox Therapeutics, which focuses on drug engineering using vesicles to deliver drugs to targets. These tiny ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

In this article, we are going to take a look at where Autolus Therapeutics plc (NASDAQ:AUTL) stands against the other best biotech penny stocks to invest in now. Goldman Sachs has spotlighted an ...

Two years ago, Eli Lilly started working with Dexcom to integrate continuous glucose monitoring (CGM) into its insulin delivery devices, and it has now firmed up the alliance. Lilly has taken a ...

Los Angeles officials told most evacuees from the wildfires to stay away from their homes at least another week as emergency responders remove toxic waste from incinerated neighborhoods and cut ...

Litecoin Positioned to Become Third US Spot Crypto ETF: Report ...

U.S. Food and Drug Administration (FDA) Commissioner Robert Califf testifies before a House Appropriations Subcommittee hearing on President Biden's proposed budget request for the FDA for fiscal ...